REMAP Trial for Optimizing Surgical Outcomes at UPMC

PHASE3TerminatedINTERVENTIONAL
Enrollment

302

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

September 23, 2022

Study Completion Date

September 23, 2022

Conditions
Aging
Interventions
DRUG

Metformin ER

tablet

DRUG

Placebo

Matched placebo in doses of 1, 2 and 3 tablets to coincide with the 500, 1000, and 1500 mg arms.

Trial Locations (1)

15213

UPMC, Pittsburgh

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Pittsburgh Medical Center

OTHER

collaborator

Berry Consultants

OTHER

lead

Matthew Neal MD

OTHER

NCT03861767 - REMAP Trial for Optimizing Surgical Outcomes at UPMC | Biotech Hunter | Biotech Hunter